Evidence map›Paper›PMID 36865970›Full record

ArticleCureus2023

An Extranodal Site of Diffuse Large B-cell Lymphoma Presenting as Ovarian Cancer.

Laila Jaouani, Adil Zaimi, Ouissam Al Jarroudi, Soufiane Berhili, Sami Aziz Brahmi, Said Afqir

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 3 countries.

Laila JaouaniFaculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Adil ZaimiMedical Oncology, Hassan II Oncology Centre, Mohammed VI University Hospital, Oujda, MAR.
Ouissam Al JarroudiMedical Oncology, Mohammed VI University Hospital, Oujda, MAR.
Soufiane BerhiliRadiation Oncology, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Sami Aziz BrahmiMedical Oncology, Mohammed VI University Hospital, Oujda, MAR.
Said AfqirMedical Oncology, Hassan II Oncology Centre, Mohammed VI University Hospital, Oujda, MAR.
Texas Oncology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to its uncommon nature, primary ovarian lymphoma has no clinical particularities and can be confused with other ovarian cancers. It poses a twofold diagnostic and therapeutic challenge. An anatomopathological and immunohistochemical study is the crucial step in the diagnosis. Our case was a 55-year-old woman diagnosed with an Ann Arbor stage II E ovarian non-Hodgkin's lymphoma who initially presented with a painful pelvic mass. This case reflects the major role of an immunohistochemical study in the diagnosis workup, leading to the appropriate management of such rare tumors.

Indexed as

cd20+exploratory laporotomyimmunohistochemical panelovarian lymphomar-chop-rituximab

Identifiers

PMID36865970
PMCPMC9973535
OpenAlexW4318428407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.